Relapsed and refractory diffuse large B - cell lymphoma
Conditions
Interventions
Relapsed and refractory group:None
Non - relapsed and non - refractory group:None
Sponsors
The Second Affiliated Hospital of the Army Medical University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Aged >= 18 years old and pathologically diagnosed with diffuse large B - cell lymphoma (DLBCL); 2.Have received standard first-line treatment regimens such as R-CHOP; 3.Have complete clinical data (including baseline characteristics, treatment regimens, recurrence and refractoriness information) and PET/CT imaging materials (including at least baseline, mid-term efficacy assessment and follow-up images).
Exclusion criteria
Exclusion criteria: 1.Combined with other types of malignant tumors; 2.The quality of PET/CT images is poor (such as severe motion artifacts and unclear lesion display); 3.Key indicators (such as pathological subtype, treatment response assessment results) are missing in the clinical data.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Relapsed and refractory state; | — |
Secondary
| Measure | Time frame |
|---|---|
| Progression free survival;Overall Survival; | — |
Countries
China
Contacts
Public ContactSong Zhang
The Second Affiliated Hospital of the Army Medical University
Outcome results
None listed